Physician profile
Fernando Striedinger
NPI 1851483119
$22,643.82
in general payments reported to CMS, 2019-2025
54 companies · $3,898 in 2025
The $3,898 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,892 · 2020: $3,150 · 2021: $3,527 · 2022: $2,862 · 2023: $2,116 · 2024: $3,200 · 2025: $3,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,796 · Education: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,795.82 |
| Education | $418.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,988.30 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $3,037.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,926.17 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,863.32 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $1,728.90 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $1,294.74 | 2019-2023 | |
| Amarin Pharma, INC. | $956.32 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $898.18 | 2021-2025 | |
| Amgen INC. | $895.00 | 2019-2025 | Repatha, Repatha, Otezla |
| Corcept Therapeutics | $569.00 | 2024-2025 | Korlym |
| Pfizer INC. | $555.79 | 2019-2025 | |
| Abbvie INC. | $507.20 | 2019-2025 | Synthroid |
| Merck Sharp & Dohme LLC | $354.56 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $308.82 | 2019-2025 | Zoryve |
| Mannkind Corporation | $296.09 | 2020-2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $273.46 | 2020-2025 | Linzess |
| Janssen Pharmaceuticals, INC | $248.88 | 2019-2021 | |
| Madrigal Pharmaceuticals | $221.01 | 2025 | Rezdiffra |
| Novartis Pharmaceuticals Corporation | $212.26 | 2022-2025 | |
| Esperion Therapeutics, INC. | $205.30 | 2020-2025 | Nexletol |
| Ibsa Pharma INC. | $193.91 | 2021-2024 | Tirosint, Licart, Licart |
| Horizon Therapeutics Plc | $149.79 | 2021-2023 | Krystexxa |
| Radius Health, INC. | $146.71 | 2025 | Tymlos |
| Sumitomo Pharma America, INC. | $144.81 | 2024-2025 | Gemtesa |
| Redhill Biopharma INC. | $122.67 | 2020-2021 | |
| Abbott Laboratories | $119.67 | 2019-2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.68 | 2023-2024 | Xifaxan, Trulance |
| Ardelyx, INC. | $113.10 | 2024-2025 | Ibsrela |
| Dexcom, INC. | $110.87 | 2023-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $98.20 | 2024 | Voquezna |
| Allergan, INC. | $81.23 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $70.49 | 2023-2024 | Edarbi, Edarbi |
| Arbor Pharmaceuticals, INC. | $69.41 | 2019-2020 | |
| Lundbeck LLC | $68.75 | 2021 | |
| Inspire Medical Systems, INC. | $67.39 | 2023-2025 | Inspire |
| Philips North America LLC | $64.13 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $56.48 | 2019 | |
| Shield Therapeutics INC | $52.08 | 2022-2024 | |
| Watermark Medical, INC. | $48.65 | 2022 | |
| Paratek Pharmaceuticals, INC. | $48.21 | 2024-2025 | Nuzyra |
| Lucid Diagnostics INC. | $46.62 | 2023-2024 | |
| Hologic Sales and Service, LLC | $44.19 | 2022-2023 | Aptima |
| Xeris Pharmaceuticals, INC. | $38.55 | 2025 | Gvoke Hypopen |
| Seqirus USA INC | $35.93 | 2024-2025 | Flucelvax, Fluad |
| Biohaven Pharmaceutical Holding Company Ltd. | $34.23 | 2022 | |
| Idorsia Pharmaceuticals US INC | $31.26 | 2023 | Quviviq |
| Genzyme Corporation | $21.67 | 2022 | |
| Boston Scientific Corporation | $21.15 | 2024 | Watchman Access System |
| Edwards Lifesciences Corporation | $20.75 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Echosens North America, INC. | $19.97 | 2025 | Fibroscan |
| Theracosbio, LLC | $14.75 | 2024 | Brenzavvy |
| Orthogenrx INC. | $13.20 | 2020 | |
| Circassia INC. | $12.49 | 2019 | |
| Linus Health, INC. | $6.50 | 2024 | Core Cognitive Evaluation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Striedinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.